Effects of drug donations in kind debated

The effects of branded drug donations by manufacturers have been debated with claims that these "harm" the development of sustainable low-cost  drug manufacturers in poorer countries, while others note the benefit  of high-quality products targeting what are sometimes neglected  diseases. Writing in The Lancet, Brook Baker, a professor at the US  Northeastern University's School of Law, and Eva Ombaka, of the  Kenya-based Ecumenical Pharmaceutical Network, argued the case for "the  danger of in-kind drug donations to the Global Fund to fight AIDS,  tuberculosis and malaria."